Abstract
Purpose:To determine the outcome and predictive factors of clinical success of bronchial artery embolization in life-threatening hemoptysis.Material and Methods:We reviewed all bronchial artery embolization procedures performed for life-threatening hemoptysis between January 2008 and December 2018. The outcomes and predictive factors of clinical success following embolization were evaluated.Results:One hundred and eighty-four bronchial artery embolization procedures performed in 145 patients were eligible for the study. The technical and clinical success rates of the procedures were 170/184 (92.4%) and 129/184 (70.1%), respectively. The unstable hemodynamics and prothrombin time/international normalized ratio >1.5 was associated with lower clinical success rate, while embolization of more than one vessel was associated with higher clinical success rate.Conclusion:Bronchial artery embolization is a safe and effective procedure for controlling bleeding in life-threatening hemoptysis. However, low clinical success rate was noted in patients with unstable hemodynamics and coagulopathy, while multiple vessel embolization was associated with higher clinical success.
Highlights
Hemoptysis is defined as expectoration of blood originating from the tracheobronchial tree or pulmonary parenchyma
A handful of studies evaluated the predictive factors of recurrent hemoptysis, no study evaluated the predictive factors of clinical success rate
The exclusion criteria were patients who had hemoptysis caused by pulmonary circulation or prophylactic and/ or elective bronchial artery embolization (BAE)
Summary
Hemoptysis is defined as expectoration of blood originating from the tracheobronchial tree or pulmonary parenchyma. Since its introduction by Remy et al [2] as an alternative to surgery, bronchial artery embolization (BAE) has established itself as the first-line treatment of life-threatening hemoptysis. It is a minimally invasive endovascular procedure with lower morbidity and mortality as compared with surgery. Several studies have validated the efficacy and safety of BAE. It has a high technical and clinical success rate with an acceptable major complication rate [3,4]. A handful of studies evaluated the predictive factors of recurrent hemoptysis, no study evaluated the predictive factors of clinical success rate
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
